Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

13.27 -0.11 (-0.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neuropace, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
Three-year data from NeuroPace’s Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentation 
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
What 4 Analyst Ratings Have To Say About NeuroPace ↗
 
Via Benzinga
News headline image
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings For NeuroPace ↗
 
Via Benzinga
News headline image
Recap: NeuroPace Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: NeuroPace ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 4, 2025 ↗
 
Via Benzinga
News headline image
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday. 
Via Benzinga
Topics Stocks
News headline image
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts ↗
 
Via Benzinga
News headline image
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q2 2024 ↗
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024 ↗
NPCE stock results show that NeuroPace met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
Breaking Down NeuroPace: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Expert Ratings for NeuroPace ↗
 
Via Benzinga
News headline image
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023 ↗
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio ↗
Stocks for financial freedom are generational companies that are well-run, growing fast, and focused on the future. 
Via InvestorPlace
News headline image
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
Expert Ratings for NeuroPace ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 5, 2024 ↗
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
News headline image
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
RNS System featured in over 50 Scientific Presentations and Posters 
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
News headline image
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position ↗
Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.